Aoyang Health released its 2026 interim report, with net profit attributable to the parent company of 24.16 million yuan, down 23.42% from the same period last year. Total operating revenue was 823 million yuan, down 8.89% year-on-year. Net cash flow from operating activities was negative 49.77 million yuan, marking a second consecutive year of improvement. The latest asset-liability ratio was 89.84%, gross margin was 12.04%, return on equity was 12.08%, and diluted earnings per share was 0.03 yuan.
Jiangsu Aoyang Technology LtdNet profit fell 23.42% year-on-year, revenue down 8.89%, and operating cash flow negative.
